Atle Magne Nekkøy • 1960 • Florø • 7 roles • 10 shareholdings

This website uses cookies to enhance the user experience.

Roles

Management

Name	Role	Total operating income	Total equity	Shares
S STEINBITEN AS	Managing Director/CEO	251,393	10,914,657	100 % directly
N NEKKØY MARINA AS	Managing Director/CEO	160,000	79,271	33.33 % indirectly
N NYE BLUEFIN AS	Managing Director/CEO	34,078,339	31,192,205	26.67 % indirectly

Boards

Name	Role	Total operating income	Total equity	Shares
S STEINBITEN AS	Chairman	251,393	10,914,657	100 % directly
N NEKKØY MARINA AS	Chairman	160,000	79,271	33.33 % indirectly
N NYE BLUEFIN AS	Chairman	34,078,339	31,192,205	26.67 % indirectly
S SAMEIET BLEKEBAKKEN 6	Board Member	-	-	-

Last update: Jun 9, 2023

Related industries3

Direct relationships5

BT
Benjamin Thomas Nekkøy1981
NYE BLUEFIN AS, NEKKØY MARINA AS
SN
Steinar Nekkøy1957
NYE BLUEFIN AS, NEKKØY MARINA AS
KR
Kjell Rune Nekkøy1953
NYE BLUEFIN AS
BM
Britt Marie Reksten-Nekkøy1966
STEINBITEN AS
HG
Hanna Grieg Sæthre2000
SAMEIET BLEKEBAKKEN 6

Shares owned by Atle Magne Nekkøy

Name	Share class	Total operating income	Total equity	Share
S STEINBITEN AS	Ordinære aksjer	251,393	10,914,657	100 % directly
N NEKKØY MARINA AS		160,000	79,271	33.33 % indirectly
N NYE BLUEFIN AS		34,078,339	31,192,205	26.67 % indirectly
S SALMON EVOLUTION ASA	NO0010892094	29,376,000	2,164,477,000	0.03 % directly < 0.01 %
A ATLANTIC SAPPHIRE ASA	NO0013249896	6,665,000	2,785,922,000	< 0.01 % directly
E EQUINOR ASA	NO0010096985	72,543,000,000	41,090,000,000	< 0.01 % directly
S SCATEC ASA	NO0010715139	1,428,000,000	11,389,000,000	< 0.01 % directly
N NYKODE THERAPEUTICS ASA	NO0010714785	9,158,000	140,142,000	< 0.01 % directly
P PCI BIOTECH HOLDING ASA	NO0010405640	0	43,986,000	< 0.01 % directly
B BERGENBIO ASA	NO0013251173	1,036,000	126,828,000	< 0.01 % directly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025